Value of Serum Human Epidermal Growth Factor Receptor 2 (HER2)/neu Testing for Early Prediction of Response to HER2/neu-Directed Therapies Is Still an Open One and Deserves Further Study in Large Prospective Trials

被引：11
|
作者：
Ali, Suhail M. [1 ,2 ]
Leitzel, Kim [1 ,2 ]
Lipton, Allan [1 ,2 ]
Carney, Walter P. [3 ]
Koestler, Wolfgang J. [4 ]
机构：
[1] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
[2] Lebanon VAMC, Lebanon, PA USA
[3] Oncogene Sci Siemens HealthCare Diagnost, Cambridge, MA USA
[4] Med Univ Vienna, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 36期
关键词：
METASTATIC BREAST-CANCER; TRASTUZUMAB;
D O I：
10.1200/JCO.2009.23.4674
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e273 / e273
页数：1
相关论文
共 50 条
  • [31] Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer
    Kim, Min Chong
    Kang, Su Hwan
    Choi, Jung Eun
    Bae, Young Kyung
    JOURNAL OF BREAST CANCER, 2020, 23 (05) : 484 - 497
  • [32] Pilot Study to Assess the Utility of Testing for Circulating HER2/Neu in the Serum of Breast Cancer Patients
    Morgan, Sarah A. L.
    Seth, Arun
    Ametniya, Yutaka
    Parra-Herran, Carlos
    Slodkowska, Elzbieta
    Lu, Fang-I
    Nofech-Mozes, Sharon
    Trudeau, Maureen
    Hanna, Wedad
    MODERN PATHOLOGY, 2017, 30 : 60A - 60A
  • [33] Strong epidermal growth factor receptor expression but not HER2/neu expression correlates with cell proliferation in anal canal carcinomas
    Hui, YZ
    Noffsinger, AE
    Miller, MA
    Hurtubise, P
    Fenoglio-Preiser, CM
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 1999, 7 (04) : 193 - 203
  • [34] Pilot Study to Assess the Utility of Testing for Circulating HER2/Neu in the Serum of Breast Cancer Patients
    Morgan, Sarah A. L.
    Seth, Arun
    Amemiya, Yutaka
    Parra-Herran, Carlos
    Slodkowska, Elzbieta
    Lu, Fang-I
    Nofech-Mozes, Sharon
    Trudeau, Maureen
    Hanna, Wedad
    LABORATORY INVESTIGATION, 2017, 97 : 60A - 60A
  • [35] Human epidermal growth factor receptor 2 (HER2) expression in urothelial carcinomas of the bladder
    Nalwa, A.
    Elhence, A. B. S. P.
    Bharti, J. Naresh
    Rao, M.
    Choudhary, G. Ram
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S170 - S171
  • [36] Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies
    Rockberg, Johan
    Schwenk, Jochen M.
    Uhlen, Mathias
    MOLECULAR ONCOLOGY, 2009, 3 (03) : 238 - 247
  • [37] Development of a monoclonal antibody against human epidermal growth factor receptor 2 (HER2)
    Takei, Junko
    Kaneko, Mika
    Ohishi, Tomokazu
    Sayama, Yusuke
    Kawada, Manabu
    Harada, Hiroyuki
    Kato, Yukinari
    CANCER SCIENCE, 2021, 112 : 545 - 545
  • [38] Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
    Siena, S.
    Sartore-Bianchi, A.
    Marsoni, S.
    Hurwitz, H. I.
    McCall, S. J.
    Penault-Llorca, F.
    Srock, S.
    Bardelli, A.
    Trusolino, L.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1108 - 1119
  • [39] INVERSE RELATIONSHIP OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND HER2/NEU GENE-EXPRESSION IN HUMAN RENAL-CELL CARCINOMA
    WEIDNER, U
    PETER, S
    STROHMEYER, T
    HUSSNATTER, R
    ACKERMANN, R
    SIES, H
    CANCER RESEARCH, 1990, 50 (15) : 4504 - 4509
  • [40] Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor
    Yokoi, A
    McCrudden, KW
    Huang, JZ
    Kim, ES
    Soffer, SZ
    Frischer, JS
    Serur, A
    New, T
    Yuan, J
    Mansukhani, M
    O'Toole, K
    Yamashiro, DJ
    Kandel, JJ
    JOURNAL OF PEDIATRIC SURGERY, 2003, 38 (11) : 1569 - 1573
12345